Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-206012
Filing Date
2017-06-16
Accepted
2017-06-16 16:17:27
Documents
5
Effectiveness Date
2017-06-16

Document Format Files

Seq Description Document Type Size
1 S-8 d405567ds8.htm S-8 59960
2 EX-5 d405567dex5.htm EX-5 4916
3 EX-23.1 d405567dex231.htm EX-23.1 1450
4 GRAPHIC g405567g13e29.jpg GRAPHIC 6529
5 GRAPHIC g405567g60d92.jpg GRAPHIC 6600
  Complete submission text file 0001193125-17-206012.txt   85962
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218799 | Film No.: 17916350
SIC: 2836 Biological Products, (No Diagnostic Substances)